- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.11. | Electra Therapeutics secures regulatory designations and funding for lead sHLH candidate | ||
| 06.11. | A new advent of clinical pathway management | ||
| 05.11. | Sandoz to acquire Just-Evotec Biologics to strengthen biosimilar development and manufacturing capabilities | ||
| 05.11. | Novo Nordisk reports sales growth in 2025 as R&D pipeline advances | ||
| 05.11. | Resilience - the importance of maintaining our well-being | ||
| 04.11. | Lilly announces plan for new $3bn facility to boost manufacturing in Europe | ||
| 04.11. | Uniphar strengthens US leadership team amid expansion | ||
| 04.11. | Physician-driven, AI-supported: addressing the clinical trial access gap | ||
| 03.11. | Novartis reports positive phase 3 results for Cosentyx in polymyalgia rheumatica | ||
| 03.11. | Uniphar announces US expansion and company integration | ||
| 03.11. | Turning connection into action: VML Health's first Patient Advocacy Summit ignites collaboration in Berlin | ||
| 03.11. | Creativity cages | ||
| 31.10. | Novartis presents new positive data for rheumatic autoimmune disease treatment | ||
| 31.10. | Lilly to invest $1.2bn in Puerto Rico manufacturing site | ||
| 31.10. | A quest for the crown: ruling digital relevance in the age of LLMs | ||
| 31.10. | The three non-negotiable pillars of Alzheimer's blood testing | ||
| 30.10. | Kyowa Kirin and University Hospitals Birmingham announce new survival data in rare disease study | ||
| 30.10. | UCB's Finteplap shows positives results for Lennox-Gastaut syndrome | ||
| 30.10. | Navigating the 'Patient Metro' - a journey full of insights | ||
| 29.10. | FDA Fast Track designation given to Enterome's follicular lymphoma treatment | ||
| 29.10. | Medicus Pharma recruits first patient in cancer patch trial | ||
| 29.10. | Aspire Pharma - enhancing the patient experience through stakeholder engagement | ||
| 28.10. | GSK's Blenrep approved by FDA for multiple myeloma | ||
| 28.10. | Medherant announces positive phase 1 results for testosterone patch for women | ||
| 28.10. | From insight to impact: strengthening stakeholder engagement across the patient journey |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .